These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24325869)

  • 1. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
    Jeong HM; Choi YH; Lee SH; Lee KY
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription.
    Jang WG; Kim EJ; Kim DK; Ryoo HM; Lee KB; Kim SH; Choi HS; Koh JT
    J Biol Chem; 2012 Jan; 287(2):905-15. PubMed ID: 22102412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMILE inhibits BMP-2-induced expression of osteocalcin by suppressing the activity of the RUNX2 transcription factor in MC3T3E1 cells.
    Jang H; Kim EJ; Park JK; Kim DE; Kim HJ; Sun WS; Hwang S; Oh KB; Koh JT; Jang WG; Lee JW
    Bone; 2014 Apr; 61():10-8. PubMed ID: 24389415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
    Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
    J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.
    Lee KN; Jang WG; Kim EJ; Oh SH; Son HJ; Kim SH; Franceschi R; Zhang XK; Lee SE; Koh JT
    J Biol Chem; 2012 Jun; 287(23):18888-99. PubMed ID: 22493443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
    Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
    Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor Lmx1b Negatively Regulates Osteoblast Differentiation and Bone Formation.
    Kim K; Kim JH; Kim I; Seong S; Han JE; Lee KB; Koh JT; Kim N
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
    J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells.
    Makita N; Suzuki M; Asami S; Takahata R; Kohzaki D; Kobayashi S; Hakamazuka T; Hozumi N
    Gene; 2008 Apr; 413(1-2):8-17. PubMed ID: 18321663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
    Wang G; Zhang X; Yu B; Ren K
    Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP2-dependent gene regulatory network analysis reveals Klf4 as a novel transcription factor of osteoblast differentiation.
    Yu S; Guo J; Sun Z; Lin C; Tao H; Zhang Q; Cui Y; Zuo H; Lin Y; Chen S; Liu H; Chen Z
    Cell Death Dis; 2021 Feb; 12(2):197. PubMed ID: 33608506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
    Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
    J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity.
    Léotoing L; Davicco MJ; Lebecque P; Wittrant Y; Coxam V
    Mol Nutr Food Res; 2014 Jun; 58(6):1239-48. PubMed ID: 24535991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.